(Q62107304)
Statements
Efficacy and safety of prophylaxis with once-weekly BAY 79-4980 compared with thrice-weekly rFVIII-FS in haemophilia A patients. A randomised, active-controlled, double-blind study (English)
Andrzej Hellmann
Jerry Powell
Uri Martinowitz
Giovanni Di Minno
Ingrid Pabinger
Monika Maas Enriquez
Lawrence Schwartz
Jørgen Ingerslev
LipLong Study Investigators